Overview
This case study demonstrates Excelra’s expertise in identifying genomic biomarkers for cell line differentiation for a US-based Food & Beverage organization operating in the veterinary domain. By leveraging advanced bioinformatics solutions and scientific data management practices, Excelra enabled precise differentiation of chicken (Gallus gallus) cell lines using high-confidence genomic variants, reducing dependency on repeated whole-genome sequencing.
Our client
The client is a US-based Food & Beverage company working in veterinary research and development. Their focus was on differentiating closely related chicken cell lines for downstream genetic studies and precision veterinary applications. To support this initiative, the client partnered with Excelra for robust scientific informatics services and genomic data analysis.
Client’s challenge
The primary challenge was to accurately differentiate multiple chicken cell lines derived from embryonic samples using reliable genomic markers. Traditional whole-genome sequencing approaches were resource-intensive and time-consuming. The client required a scalable and cost-effective strategy to identify genomic biomarkers for cell line differentiation with high confidence while maintaining reproducibility and data integrity in line with FAIR data principles.
Client’s goals
The client aimed to identify lineage-specific genomic variants (SNPs, SNVs, and indels) that could reliably distinguish cell lines and match them back to their embryonic origin. A secondary goal was to develop PCR-based assays to replace repeated sequencing, enabling faster and more economical cell line authentication supported by structured scientific data management.
Our approach
Excelra implemented a structured, multi-step bioinformatics workflow beginning with stringent quality control of sequencing reads and exon-level coverage assessment. High-quality variants were identified using industry-standard pipelines and filtered based on allelic depth, heterozygosity ratios, and coverage metrics. This approach aligns with best practices outlined in our data-driven analytics methodologies.
Variants were compared across cell lines and embryonic DNA samples to identify private and shared markers. Leveraging bioinformatics applications and sequence analysis expertise, Excelra selected exon-localized variants with the highest confidence for downstream assay development, ensuring robust genomic biomarkers for cell line differentiation.
Our solution
Excelra developed multiple unique PCR primer pairs for each cell line, enabling unambiguous identification without the need for repeated whole-genome sequencing. The final deliverables included curated variant lists detailing chromosomal location, quality scores, read depth, and allele information. These datasets were structured for downstream reuse, aligning with principles discussed in our FAIR data and data fairification resources.
Result
The implemented solution successfully distinguished all cell lines using unique genomic marker signatures and accurately matched them to their embryos of origin. By replacing repeated sequencing with PCR-based assays, the client achieved significant time and cost savings. The high-confidence biomarker dataset now supports future applications such as veterinary precision medicine, lineage tracking, and genetic quality control—key components of data-driven precision medicine.
Conclusion
This project highlights Excelra’s ability to deliver scalable and reproducible genomic biomarkers for cell line differentiation using advanced bioinformatics and scientific informatics. By combining rigorous variant analysis, PCR assay development, and structured data delivery, Excelra enabled efficient cell line authentication while optimizing resources. The approach provides a strong foundation for future genomic and veterinary research initiatives supported by Excelra’s broader informatics and data science offerings.
